Skip to content

Colder, safer.

Ice damages cellular life. Without freezing, the possibilities are life-changing.

Learn More

Kidney Preservation

Viable for up to 7 days

Learn More

Stem Cell Preservation

Viable for up to 7 days

Learn More

About

CryoStasis’ revolutionary approach to preserving biological material traces its roots to the Canadian Arctic. Born of biochemist Olga Kukal’s fascination with the winter survival strategies of insects, our technology rejects a commonly held belief – that in order to preserve life, we must freeze it.

Our Novel Cold Chain Management Process

Storage
Chemistry

Proprietary storage solutions leverage unique cold shock inhibitors and membrane protectants to prevent cryoinjury to biological material.

Temperature
Systems

Proprietary refrigeration devices, cold packs and shipping containers provide the flexibility needed to keep biological material viable for almost any storage or shipping scenario.

Pressure
Systems

Proprietary, patent-pending pressurization technology depresses the freezing point of biological material, providing long-term enduring storage.

Adobe Stock 276021384 sm

Kidney Preservation

Until now, science has failed to keep organs viable post-harvest for more than a few hours. Our Extended Phase™️ technology enables safe kidney storage at -5°C without freezing for up to seven days, avoiding ischemic injury during the organ transplant process.

Contact Us
Adobe Stock 313579636 sm

Stem Cell Preservation

Freezing stem cells for research or therapy administration results in a high cell mortality rate, hindering patient care. Our Extended Phase™️ technology enables safe cell storage at -5°C without freezing for up to seven days, unlocking significant benefits to regenerative medicine.

Contact Us

CryoStasis is currently collaborating with some of the world's foremost stem cell research and organ transplant centres.

Latest Insights

Our Team

  • Jan Kaminski headshot

    Jan Kaminski

    Executive Chairman

    Jan brings decades of global growth and leadership experience to the CryoStasis team, including 15 years as President of Colonnade Investments. He’s guided venture-backed start-ups to successful M&As and held several advisory and board positions among a number of corporations and not-for-profits. His experience spans industries including agriculture, enterprise management, medical device technologies and more.

    LinkedIn
  • Keith Millar headshot

    Keith Millar

    Chief Executive Officer

    Keith has focused his career on disruptive products. Keith has been leading teams in various markets and industries for the last 25 years. Keith’s engineering background, MBA and leadership experience yields a powerful mix of business and technology skills. Keith has led teams in Aerospace, Healthcare, IT software & services. Keith has a proven record of successfully aligning company core competencies with customer problems.

    LinkedIn
  • Thomas Allen headshot

    Thomas Allen

    Chief Science Officer

    Tom is a physical chemist with an extensive academic and professional background. While doing a postdoctoral fellowship at Ohio State, Tom met his wife, Dr. Olga Kukal. Over the course of three decades, the two founded three biotechnical companies to actualize the transformative potential of Olga’s research. As CSO, Tom honours Olga’s memory by continuing to advance the research she began more than 40 years ago and that, together, they distilled into a life-changing technology.

    LinkedIn
  • Photis Loizides headshot

    Photis Loizides

    Chief Medical Officer

    Dr. Photis Loizides is a Plastic and Reconstructive Surgeon at Richmond Hospital and is the founder and operator of a successful Vancouver-based plastic surgery clinic. He is a Clinical Instructor of Surgery at the University of British Columbia. Fully accredited by the Royal College of Physicians and Surgeons, Photis has over a decade of experience performing reconstructive and cosmetic surgical procedures with extensive training in minimizing the effects of ischemic damage on tissues and organs.

    LinkedIn
  • Ross Morgan headshot

    Ross Morgan

    Chief Financial Officer

    Ross has more than 30 years’ senior financing, M&A, board of directors and operational experience supporting numerous early-stage, private and public companies, with a focus on high-tech. He is the current Managing Director of CFO4Results Inc., a consulting firm he acquired in 2010 and through which he’s advised dozens of companies ranging from biomedical to consumer products, patent licensing and software.

    LinkedIn
  • Chantal Hemens headshot

    Chantal Hemens

    VP Operations

    Chantal has over thirty years of combined technical and management experience in the biotech and telecommunications industries. In the past 17 years, she led teams in both small (<50) and medium (>500) size medical device organizations with focus on manufacturing, quality, and regulatory compliance. Chantal provided strategic and tactical leadership for manufacturing medical devices to achieve business critical objectives while meeting global regulatory and quality requirements and exceeding customer expectations. Chantal’s science and operations background, coupled with her passion for leading people, a strong combination with proven results.

    LinkedIn

We're on a mission to give life to research, healthcare, patients, and the world.

Join Us